Graff, Gavin R <br/><br/>
Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.  [electronic resource] 

 -  Clinical therapeutics  Jan 2010 
 - 89-103 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-114X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinthera.2010.01.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Capsules<br/>Child<br/>Cross-Over Studies<br/>Cystic Fibrosis--complications<br/>Delayed-Action Preparations<br/>Double-Blind Method<br/>Enzyme Replacement Therapy<br/>Exocrine Pancreatic Insufficiency--drug therapy<br/>Fats--metabolism<br/>Feces<br/>Female<br/>Gastrointestinal Agents--administration & dosage<br/>Humans<br/>Intestinal Absorption--drug effects<br/>Male<br/>Nitrogen--metabolism<br/>Pancrelipase--administration & dosage<br/>Placebos<br/>Steatorrhea--complications<br/>Treatment Outcome